Quick definition
MADD is a diagnostic label used in the ICD-10 system (code F41.2) when anxiety and depressive symptoms are both present and subthreshold—that is, not severe enough for a standalone anxiety disorder or major depression—and neither clearly predominates. It’s not a specific DSM-5 diagnosis, though DSM-5 allows similar presentations to be coded under other categories. See the official wording from the World Health Organization and academic reviews here:
ICD-10 F41.2 definition,
Clinical review of MADD,
Overview of ICD vs DSM.
Why the terminology can be confusing
- ICD-10 (F41.2): “Mixed anxiety and depressive disorder” for co-occurring, subsyndromal symptoms where neither dominates. Source
- DSM-5: No dedicated MADD category. Similar cases may appear as other specified/unspecified anxiety or depressive disorders, or as adjustment disorder with mixed anxiety and depressed mood when symptoms follow a stressor. DSM-5 adjustment specifiers
- Research/clinics often use “mixed anxiety–depression” informally because anxiety and depression commonly occur together in primary care. Review
Common signs & symptoms (what it feels like day to day)
People with mixed anxiety–depression typically notice:
- Persistent worry, tension, restlessness alongside low mood, loss of interest, fatigue.
- Sleep problems (trouble falling or staying asleep), irritability, and difficulty concentrating.
- Physical symptoms like muscle tension, headaches, stomach upset, or a racing heart.
- Self-critical thoughts (“I can’t cope”) plus anticipatory anxiety about the future.
Importantly, the combined picture causes meaningful impairment (work, study, relationships) but doesn’t fully meet criteria for a single disorder such as major depressive disorder or generalized anxiety disorder. Evidence summary
How it’s diagnosed
A clinician will usually:
- Take a full history of symptoms, duration, triggers, and impact.
- Rule out medical causes (thyroid, anemia, medication effects, substance use).
- Check whether you meet criteria for major depression or a specific anxiety disorder. If not, and symptoms are mixed and persistent, ICD-10’s MADD may be used; in DSM-5 contexts, an other specified category or adjustment disorder with mixed anxiety and depressed mood may be used if linked to a clear stressor. DSM-5 specifiers
Is it common?
Yes—especially in primary care. Studies suggest a large share of patients present with overlapping, subthreshold anxiety and depressive symptoms rather than neat, single-category disorders. This is one reason many health systems keep the category. Review
What causes it?
There isn’t a single cause, but risk tends to accumulate across:
- Biology: genetic vulnerability; shared neurotransmitter systems involved in mood and threat processing.
- Psychology: negative thinking patterns, avoidance behaviors that maintain both worry and low mood.
- Life stress: ongoing stressors (work, caregiving, finances), trauma history, isolation.
Research consistently shows anxiety and depression share mechanisms and often respond to similar treatments. Treatment review
Treatment that works
1) First-line therapies
- Cognitive-behavioral therapy (CBT) and related therapies (behavioral activation, problem-solving therapy) reduce both anxiety and depressive symptoms and improve functioning. Evidence
- Medications: SSRIs and SNRIs are widely used when symptoms are persistent or moderate–severe. They target overlapping biological pathways for anxiety and depression. (Examples include sertraline, escitalopram, venlafaxine—choice depends on your history and side-effect profile.) Overview of SSRIs
- Combined treatment (therapy + medication) often provides the most durable benefit when symptoms significantly affect daily life. Clinical guidance
2) Options when first-line isn’t enough
- Try a different SSRI/SNRI, or consider augmentation strategies guided by a psychiatrist.
- Explore evidence-based psychotherapies such as the Unified Protocol (for emotional disorders) or mindfulness-based CBT.
- Specialty treatments may be considered for treatment-resistant cases (e.g., esketamine nasal spray for major depression; availability and suitability vary). Background on ketamine approaches
3) Self-care strategies that make a real difference
- Behavioral activation: schedule small, meaningful activities daily (movement, sunlight, social micro-interactions).
- Worry workout: pick a 10–15 minute “worry window” to contain rumination; use the rest of the day for problem-solving.
- Sleep anchors: fixed wake time, wind-down routine, limited evening screens/caffeine.
- Body tools: paced breathing (e.g., 4-6 breaths/min), progressive muscle relaxation.
- Track and tweak: use a simple mood/worry log to spot patterns and test small changes.
How it differs from related diagnoses
- Major depressive disorder (MDD): deeper, more pervasive low mood and loss of interest for at least two weeks with additional symptoms meeting full criteria.
- Generalized anxiety disorder (GAD): excessive, hard-to-control worry more days than not for at least six months plus physical symptoms.
- Adjustment disorder with mixed anxiety and depressed mood: symptoms arise in response to a clear stressor and are time-limited relative to that stressor (DSM-5 specifier). DSM-5 table
When to seek help urgently
- If you have thoughts of harming yourself or others.
- Rapid worsening of functioning (can’t work, study, or care for yourself).
- New or severe physical symptoms (e.g., chest pain) that could indicate a medical issue.
Emergency resources vary by country—contact local emergency services or crisis lines immediately.
Practical next steps
- Screen yourself with brief tools your clinician may use (PHQ-9 for depression, GAD-7 for anxiety) and bring the scores to your appointment.
- Book a primary care or mental health visit to clarify diagnosis and create a plan.
- Start small, consistent habits (sleep, movement, scheduled activities) while you wait for care.
- Consider therapy—in person or reputable digital CBT programs. Example psychoeducation
FAQ
Is MADD “less serious” than depression or anxiety?
No. Even if symptoms are subthreshold for a single disorder, the combined impact can be substantial and deserves treatment. Review
Can it turn into a full anxiety disorder or major depression?
Yes, especially without support. Early, targeted treatment reduces that risk. Evidence
What medications are commonly used?
Clinicians often start with an SSRI or SNRI given their efficacy across anxiety and depressive symptoms; choice is individualized. Overview
What’s the difference between ICD and DSM on this?
ICD-10 includes a specific code (F41.2) for MADD; DSM-5 does not, but clinicians can use other categories (e.g., other specified disorders or adjustment disorder with mixed anxiety and depressed mood when appropriate). ICD-10 • DSM-5
Further reading (trusted sources)
- WHO ICD-10 F41.2: Mixed anxiety and depressive disorder
- The relevance of ‘mixed anxiety and depression’ (comprehensive review)
- Treating comorbid anxiety and depression (psychosocial & pharmacologic evidence)
- OpenLearn: ICD vs DSM overview of MADD
Helpful internal resources
Takeaway: Mixed anxiety–depression is common, real, and treatable. A blend of skills-based therapy, lifestyle supports, and (when needed) medication can restore momentum. If you recognize yourself here, start with a screening, schedule an appointment, and pick one small action today—consistency beats intensity.